The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Audiol. Otol.
Sec. Otology and Neurotology
Volume 2 - 2024 |
doi: 10.3389/fauot.2024.1391998
This article is part of the Research Topic Clinically Impactful Discoveries in International Temporal Bone Histopathology Laboratories Around the World View all articles
External Auditory Canal Metastasis leading to Peripheral Facial Paralysis as First manifestation of de novo stage IV Invasive Lobular Carcinoma of the Breast, report of a rare case
Provisionally accepted- 1 Catalan Institute of Oncology, Barcelona, Spain
- 2 Bellvitge University Hospital, Barcelona, Balearic Islands, Spain
Facial nerve (FN) palsy, as a solitary symptom resulting from metastatic tumor is uncommon, and metastases to the external auditory canal (EAC) are even more infrequent. In this article, we report a unique case of the novo stage IV invasive lobular breast carcinoma (ILC) presenting as an EAC metastasis and leading to FN palsy as the first symptom, highlighting the importance of considering a broad differential diagnosis.
Keywords: Peripheral facial nerve palsy, Metastatic breast adenocarcinoma, External auditory canal, Lobular breast carcinoma, Temporal bone abnormalities, case report
Received: 26 Feb 2024; Accepted: 30 Jul 2024.
Copyright: © 2024 Lluís Garulo, Alonso, Rodríguez, Manent, Gállego, Guerra Fernández, Sanjuan Garriga, Gubern Prieto, Penella Prat, Salinas Huertas, Chivite Guillen, Pernas and FALO. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
David Lluís Garulo, Catalan Institute of Oncology, Barcelona, Spain
CATALINA FALO, Catalan Institute of Oncology, Barcelona, Spain
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.